Redenlab awarded $2.5M to scale AI-driven speech biomarkers for dementia detection →
A newly formed research network focused on Batten disease, a rare and inherited brain disorder that primarily affects children, has received funding from the U.S. National Institutes of Health (NIH) to accelerate clinical research and prepare for future treatment trials.
Receiving the CUREator+ Dementia & Cognitive Decline funding marks a meaningful milestone in our journey to transform how we measure and monitor cognitive health.
Redenlab CSO contributes to a new book chapter on the Best practices for supervised machine learning when examining biomarkers in clinical populations has been included in ‘Big Data in Psychiatry & Neurology’ published by Elsevier.